Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

NCT07228832 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

600

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Colorectal Cancer (CRC)

Interventions

DRUG: Drug: Ivonescimab Injection
DRUG: Drug: Bevacizumab Injection

Sponsor

Summit Therapeutics